GC101 Gene Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GC101 Gene Therapy, covering 2025-06-05 to 2025-06-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of GC101 Gene Therapy Via Intrathecal (IT) Injectionin the Treatment of Patients With Type 2 Spinal Muscular Atrophy (SMA) - Phase III [Phase 3]